Kanzhun Limited remains a buy as Q1 underlying signals improved despite headline revenue distortion from a later Chinese New Year. Large enterprise recovery, blue-collar revenue exceeding 40% of total, and measurable AI monetization reinforce BZ's growth thesis. Margins remain robust: 85% gross, ~42% EBITDA, ~30% EBIT, with a net cash balance and attractive ~11x forward P/E valuation.